Association Between Sclerostin and Sarcopenia-Related Functional Decline in Older Women.

Background: Sclerostin, an osteocyte-derived glycoprotein, plays a key role in bone metabolism by inhibiting the Wnt/β-catenin signaling pathway. While it is a recognized therapeutic target in osteoporosis, its relationship with sarcopenia remains un…

Preview only. Read the full abstract at the source